Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers by Sara P. Myers, Varadan Sevilimedu, Andrea V. Barrio, Audree B. Tadros, Anita Mamtani, Mark E. Robson, Monica Morrow, Minna K. Lee

Get full text

Role of inducible nitric oxide (iNOS) and nitrosative stress in regulating sex differences in secondary lymphedema by Adana-Christine Campbell, Kevin G. Kuonqui, Gopika Ashokan, Jonathan Rubin, Jinyeon Shin, Bracha L. Pollack, Arielle Roberts, Ananta Sarker, Hyeung Ju Park, Raghu P. Kataru, Andrea V. Barrio, Babak J. Mehrara

Get full text

D18. Risk of Breast Cancer-Related Lymphedema: Development and Validation of a Clinically-Relevant, Patient-facing Prediction Model by Danielle H. Rochlin, MD, Andrea V. Barrio, MD, Sarah A. McLaughlin, MD, Kimberly J. Van Zee, MD, Michelle R. Coriddi, MD, Joseph H. Dayan, MD MBA, Babak J. Mehrara, MD

Get full text

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab by Emanuela Ferraro, Jasmeet Singh, Sujata Patil, Pedram Razavi, Shanu Modi, Sarat Chandarlapaty, Andrea V. Barrio, Rachna Malani, Ingo K. Mellinghoff, Adrienne Boire, Hannah Y. Wen, Edi Brogi, Andrew D. Seidman, Larry Norton, Mark E. Robson, Chau T. Dang

Get full text